SCHEMBL12123794

SCHEMBL12123794

CC(C)c1ccc(C(C(=O)O)C(C)C)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
ADRA2C P18825 1/20 0.38
MAOA P21397 1/20 0.38
ADRA1A P35348 1/20 0.38
DRD3 P35462 1/20 0.38
KCNH2 Q12809 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
CCNE1 P24864 6/20 0.34
CDK2 P24941 6/20 0.34
CDK5 Q00535 6/20 0.34
DAO P14920 1/20 0.33
CCNT1 O60563 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12123833 0.82 ALOX5 (0.38) CYP2D6CYP2C9ADRA2CMAOAADRA1A
SCHEMBL5521073 0.82 ALOX5 (0.49) CYP2D6CYP2C9ADRA2CMAOAADRA1A
SCHEMBL5521104 0.81 GABBR2 (0.46) CYP2D6CYP2C9ADRA2CMAOAADRA1A
SCHEMBL12120757 0.72 GABBR2 (0.38) CYP2D6CYP2C9ADRA2CMAOAADRA1A
SCHEMBL2141423 0.71 DAO (0.64) CYP2D6CYP2C9ADRA2CMAOAADRA1A
SCHEMBL5510009 0.71 ALOX5 (0.49) CYP2D6CYP2C9CYP3A4HPGDCYP2C19
SCHEMBL5515135 0.71 ALOX5 (0.49) CYP2D6CYP2C9CYP3A4HPGDCYP2C19
SCHEMBL26169163 0.69 UGT2B7 (0.32) ADRA2CCCNE1CDK2CDK5CCNT1
SCHEMBL5511661 0.68 ALOX5 (0.55) CYP1A2ALOX5
SCHEMBL27830232 0.68 HPGD (0.53) CYP2D6CYP2C9ADRA2CMAOAADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637549-B2 Pyridons as PDK1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-28 US disclosed
US-20110313156-A1 HETEROCYCLYL CARBONIC ACID AMIDES AS ANTIPROLIFERATIVE AGENTS, PDKL INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110269958-A1 PYRIDONS AS PDK1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-03 US disclosed
WO-2010007114-A2 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313156-A1 HETEROCYCLYL CARBONIC ACID AMIDES AS ANTIPROLIFERATIVE AGENTS, PDKL INHIBITORS PDK2, PDK4, CCNH CYP2D6 4133/4885CYP2C9 4418/4885ADRA2C 4816/4885
US-20110269958-A1 PYRIDONS AS PDK1 INHIBITORS PDK1, PDK2, PDK4 CYP2D6 894/4885CYP2C9 3524/4885ADRA2C 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.